A Combination of Intrastromal and Intracameral Injections of Amphotericin B in the Treatment of Severe Fungal Keratitis

Table 1

Clinical data of patients with severe fungal keratitis treated with combined intrastromal and intracameral amphotericin B.

Case number	Age; (years)/gender	Risk factor for; fungal keratitis	History	Duration of onset; of symptoms; (days)	Initial BCVA	Size of ulcer; (mm)	Fungal; identification	Repeated; injection	Final BCVA	Healed with
1	37/F	Corneal trauma	Diabetes	27	CF	5 × 6	Fusarium	1 Isi	20/40	Leucoma
2	56/M	Unknown	Steroid	17	HM	5.5 6.5	Not identified	2 Ici	20/200	Leucoma
3	67/M	Corneal trauma	Diabetes	35	LP	6 7	Alternaria	1 Iii	CF	Leucoma
4	71/M	Unknown	No	33	HM	6 6	Fusarium	—	CF	Leucoma
5	57/F	Corneal trauma	Steroid	39	HM	7 8	Aspergillus	2 Isi + 1 Isi	HM	Adherent leucoma
6	63/F	Contact lens	Diabetes	46	LP	6 7	Negative	—	20/300	Leucoma
7	56/M	Corneal trauma	Steroid	63	LP	5 7	Aspergillus	2 Ici	HM	Adherent leucoma
8	47/M	Unknown	No	52	HM	5.5 6.5	Fusarium	—	CF	Leucoma
9	43/M	Corneal trauma	Steroid	41	CF	6 8	Negative	—	20/200	Leucoma

CF, counting fingers; F, female; HM, hand movements; Iii, combined intrastromal and intracameral injections; Isi, intrastromal injections; Ici, intracameral injections; LP, light perception; M, male.